Bristol-Myers Wins Vote Approving $74 Billion Celgene Deal

(Bloomberg) -- Bristol-Myers Squibb Co. won a shareholder vote to approve its roughly $74 billion takeover of Celgene Corp., paving the way to close the largest pharmaceutical merger in history and...